non small cell lung cancer stage iii
Showing 1 - 12 of 12
ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC
Recruiting
- Non Small Cell Lung Cancer Stage III
- Neoadjuvant Treatment
-
Badalona, Barcelona, Spain
- +19 more
Jul 28, 2022
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Non Small Cell Lung Cancer Stage III Trial in Melbourne (Functionally adapted, dose escalated VMAT radiotherapy)
Completed
- Non Small Cell Lung Cancer Stage III
- Functionally adapted, dose escalated VMAT radiotherapy
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2022
Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Stage III, HER2 Gene Mutation Trial in France (pertuzumab +
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- pertuzumab + trastuzumab + docetaxel
-
Besançon, France
- +17 more
Mar 9, 2022
Non Small Cell Lung Cancer Stage III Trial in France (Nivolumab and Intensity Modulated Radiotherapy (IMRT))
Recruiting
- Non Small Cell Lung Cancer Stage III
- Nivolumab and Intensity Modulated Radiotherapy (IMRT)
-
Brest, France
- +4 more
Jan 25, 2022
Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage III Trial in Worldwide (Durvalumab Injection)
Recruiting
- Cancer
- +4 more
- Durvalumab Injection
-
Tallinn, Estonia
- +9 more
Dec 1, 2021
Tumor Mutational Burden in Lung Cancer Patients
Terminated
- Non Small Cell Lung Cancer
- +3 more
- TMB assessment
-
Clermont-Ferrand, Auvergne-Rhône-Alpes, France
- +7 more
Jun 23, 2021
Non Small Cell Lung Cancer Stage III, Immunotherapy Trial in Hasselt, Amsterdam, Leiden
Not yet recruiting
- Non Small Cell Lung Cancer Stage III
- Immunotherapy
-
Hasselt, Vlaanderen, BelgiumKristof Cuppens
Jan 14, 2021
Non Small Cell Lung Cancer Stage III, Small-Cell Lung Cancer Trial in Beijing (Durvalumab)
Recruiting
- Non Small Cell Lung Cancer Stage III
- Small-Cell Lung Cancer
-
Beijing, ChinaPeking Union Medical College Hospital
Dec 11, 2020
Superior Sulcus Tumor, NSCLC Stage IIB, Non Small Cell Lung Cancer Stage III Trial (drug, radiation, procedure)
Not yet recruiting
- Superior Sulcus Tumor
- +2 more
- Cisplatin
- +4 more
- (no location specified)
Jul 7, 2020
Tumor Volume and Its Changes in Radical Radiotherapy of Advanced
Completed
- Non Small Cell Lung Cancer Stage III
-
Innsbruck, Austria
- +21 more
May 1, 2018
Use of PET/CT in Radiotherapy Planning in Low and Middle Income
Unknown status
- Non Small Cell Lung Cancer Stage III
- (no location specified)
Sep 19, 2014